BACKGROUND:Survivors of lower extremity (LE) malignancies experience functional deficits. PURPOSE: The purpose of this prospective clinical trial was to determine feasibility and functional outcomes of adding pre-habilitation during the 10-12 week period prior to a planned surgery to remove the tumor in children and adolescents with a LE sarcoma. DESIGN: Pilot study. SETTING: St. Jude Children's Research Hospital (SJCRH). PATIENTS: Participants included 14 individuals between the ages of 8 and 20 years who were diagnosed with a LE sarcoma. Participant outcomes were compared to a control group of 35 individuals treated for osteosarcoma that obtained the same functional assessments but no pre-habilitation. INTERVENTION: The intervention group received strengthening exercises and mobility training 3 times per week for 30-60 minutes for 10-12 weeks preoperatively. MEASUREMENTS: Participants completed the Functional Mobility Assessment (FMA) and measures of strength and range of motion (ROM) of bilateral lower extremities (BLEs) at baseline, after 10-12 weeks of preoperative PT, and at 20-22 weeks. RESULTS: Twelve participants completed at least 50% of their schedule pre-habilitative sessions. The intervention group scored significantly better on the FMA than the control group at weeks 20-22 (35.6 vs. 25.7, p .0267). No significant difference was found in ROM or strength. LIMITATIONS: Due to this study being a pilot study, the sample size was small. Therefore, we cannot infer generalizability. CONCLUSIONS: Findings suggest that those diagnosed with a LE malignancy awaiting a limb sparing procedure or amputation participate in at least 50% of scheduled PT sessions and benefit from them.
RCT Entities:
BACKGROUND: Survivors of lower extremity (LE) malignancies experience functional deficits. PURPOSE: The purpose of this prospective clinical trial was to determine feasibility and functional outcomes of adding pre-habilitation during the 10-12 week period prior to a planned surgery to remove the tumor in children and adolescents with a LE sarcoma. DESIGN: Pilot study. SETTING: St. Jude Children's Research Hospital (SJCRH). PATIENTS: Participants included 14 individuals between the ages of 8 and 20 years who were diagnosed with a LE sarcoma. Participant outcomes were compared to a control group of 35 individuals treated for osteosarcoma that obtained the same functional assessments but no pre-habilitation. INTERVENTION: The intervention group received strengthening exercises and mobility training 3 times per week for 30-60 minutes for 10-12 weeks preoperatively. MEASUREMENTS: Participants completed the Functional Mobility Assessment (FMA) and measures of strength and range of motion (ROM) of bilateral lower extremities (BLEs) at baseline, after 10-12 weeks of preoperative PT, and at 20-22 weeks. RESULTS: Twelve participants completed at least 50% of their schedule pre-habilitative sessions. The intervention group scored significantly better on the FMA than the control group at weeks 20-22 (35.6 vs. 25.7, p .0267). No significant difference was found in ROM or strength. LIMITATIONS: Due to this study being a pilot study, the sample size was small. Therefore, we cannot infer generalizability. CONCLUSIONS: Findings suggest that those diagnosed with a LE malignancy awaiting a limb sparing procedure or amputation participate in at least 50% of scheduled PT sessions and benefit from them.
Authors: Victoria G Marchese; Shesh N Rai; Claire A Carlson; Pamela S Hinds; Elena M Spearing; Lijun Zhang; Lulie Callaway; Michael D Neel; Bhaskar N Rao; Jill P Ginsberg Journal: Pediatr Blood Cancer Date: 2007-08 Impact factor: 3.167
Authors: A J Provisor; L J Ettinger; J B Nachman; M D Krailo; J T Makley; E J Yunis; A G Huvos; D L Betcher; E S Baum; C T Kisker; J S Miser Journal: J Clin Oncol Date: 1997-01 Impact factor: 44.544
Authors: Israel Fernandez-Pineda; M M Hudson; A S Pappo; M W Bishop; J L Klosky; T M Brinkman; D K Srivastava; M D Neel; B N Rao; A M Davidoff; K R Krull; D A Mulrooney; L L Robison; K K Ness Journal: J Cancer Surviv Date: 2016-06-04 Impact factor: 4.442
Authors: Favil Singh; Robert U Newton; Michael K Baker; Nigel A Spry; Dennis R Taaffe; Jeffery Thavaseelan; Daniel A Galvão Journal: Integr Cancer Ther Date: 2016-09-01 Impact factor: 3.279
Authors: Michael W Bishop; Kirsten K Ness; Chenghong Li; Wei Liu; Deo Kumar Srivastava; Wassim Chemaitilly; Kevin R Krull; Daniel M Green; Alberto S Pappo; Leslie L Robison; Melissa M Hudson; Daniel A Mulrooney Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-06-04 Impact factor: 4.254
Authors: Regine Söntgerath; Julia Däggelmann; Sabine V Kesting; Corina S Rueegg; Torge-Christian Wittke; Simon Reich; Katharina G Eckert; Sandra Stoessel; Carolina Chamorro-Viña; Joachim Wiskemann; Peter Wright; Anna Senn-Malashonak; Vanessa Oschwald; Anne-Marie Till; Miriam Götte Journal: Pediatr Res Date: 2021-04-15 Impact factor: 3.953
Authors: Michael D Wood; Kim Correa; Peijia Ding; Rama Sreepada; Kent C Loftsgard; Isabel Jordan; Nicholas C West; Simon D Whyte; Elodie Portales-Casamar; Matthias Görges Journal: JMIR Pediatr Parent Date: 2022-07-15
Authors: Brooke E Kohler; Carolina X Sandler; Emmah Baque; Natalie K Bradford; Stewart G Trost Journal: Front Pediatr Date: 2022-09-16 Impact factor: 3.569
Authors: Paula A Ospina; Alyssa McComb; Lesley E Pritchard-Wiart; David D Eisenstat; Margaret L McNeely Journal: Cochrane Database Syst Rev Date: 2021-08-03
Authors: Christa M Nelson; Victoria Marchese; Kelly Rock; Robert M Henshaw; Odessa Addison Journal: Front Pediatr Date: 2020-06-16 Impact factor: 3.569